Suppr超能文献

血小板源性生长因子结合蛋白:一种新型诊断性免疫组化标志物。

Podoplanin: a novel diagnostic immunohistochemical marker.

作者信息

Ordóñez Nelson G

机构信息

University of Texas, Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Adv Anat Pathol. 2006 Mar;13(2):83-8. doi: 10.1097/01.pap.0000213007.48479.94.

Abstract

Podoplanin is a transmembrane mucoprotein recognized by the recently commercially available D2-40 monoclonal antibody. Recent investigations have shown that podoplanin is selectively expressed in lymphatic endothelium as well as lymphangiomas, Kaposi sarcomas, and in a subset of angiosarcomas with probable lymphatic differentiation. Podoplanin has also been shown to be strongly expressed in seminomas, epithelioid mesotheliomas, and hemangioblastomas, and immunostaining for this marker can assist in the diagnosis of these tumors. This article reviews the current information on the applications of podoplanin immunostaining in surgical pathology.

摘要

血小板源性生长因子受体是一种跨膜粘蛋白,可被最近上市的D2-40单克隆抗体识别。最近的研究表明,血小板源性生长因子受体在淋巴管内皮以及淋巴管瘤、卡波西肉瘤和一部分可能具有淋巴管分化的血管肉瘤中选择性表达。血小板源性生长因子受体在精原细胞瘤、上皮样间皮瘤和血管母细胞瘤中也有强烈表达,对该标志物进行免疫染色有助于这些肿瘤的诊断。本文综述了血小板源性生长因子受体免疫染色在外科病理学中的应用的当前信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验